ALLISON MULLIN: Open Payments
NPI 1548651151 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 24 payments from 9 companies in 2025. Trend: 2023 $457 · 2024 $236 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $132 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: LifeVest, LEQVIO, REPATHA, Wegovy, JARDIANCE, FARXIGA, CAPVAXIVE, ELIQUIS.
Industry payments across NC — which companies pay providers there.
